RecruitingNCT05887700
Lifetech CeraFlex™ ASD Closure System Post-Market Clinical Follow-Up
Studying Interatrial communication
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Lifetech Scientific (Shenzhen) Co., Ltd.
- Intervention
- CeraFlex™ Atrial Septal Defect (ASD) Closure System(device)
- Enrollment
- 145 target
- Eligibility
- All sexes
- Timeline
- 2024 – 2027
Study locations (7)
- Hospital Pequeno Príncipe, Curitiba, Brazil
- Universidade Federal do Ceará, Fortaleza, Brazil
- Santa Casa de Misericórdia de Porto Alegre, Porto Alegre, Brazil
- HCOR - Associação Beneficente Síria, São Paulo, Brazil
- Hospital Beneficência Portuguesa, São Paulo, Brazil
- Onassis Cardiac Surgery Center, Kallithea, Greece
- IRCCS Policlinico San Donato, Milan, Italy
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05887700 on ClinicalTrials.govOther trials for Interatrial communication
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT06849635Cera™ ASD Occluder Post-Market Clinical Follow-Up StudyLifetech Scientific (Shenzhen) Co., Ltd.
- RECRUITINGNCT06700174Lifetech AcuMark™ Sizing Balloon Post-Market Clinical Follow-up StudyLifetech Scientific (Shenzhen) Co., Ltd.
- RECRUITINGNCT06590467Abbott Structural Heart Device RegistryAbbott Medical Devices
- RECRUITINGPHASE4NCT06631534Effect of Dexmedetomidine Supplementation to General Anaesthesia in Paediatric Transcatheter Closure of Atrial Septal DefectAlexandria University
- RECRUITINGNCT06347276Cerebral Microembolization Associated With PFO ClosureChina National Center for Cardiovascular Diseases
- RECRUITINGNANCT02097758Efficacy of Three Dimensional Transesophageal Echocardiography for Percutaneous Device Closure in Atrial Septal DefectAsan Medical Center